{"id":"https://genegraph.clinicalgenome.org/r/c95022e4-ff23-4000-816d-b5bfcc4a5e0fv1.0","type":"EvidenceStrengthAssertion","dc:description":"ARID1B was reported in relation to autosomal dominant Coffin-Siris syndrome by three different groups around the same time in 2012 (Tsurusaki, et al., PMID: 22426308; Santen, et al., PMID: 22426309; Hoyer, et al., PMID: 22405089). Coffin-Siris syndrome is characterized by intellectual disability associated with coarse facial features, hypertrichosis, sparse scalp hair, and hypoplastic or absent fifth fingernails or toenails. More than 170 unique pathogenic or likely pathogenic variants in ARID1B have been reported in ClinVar, with the majority of them de novo truncating variants (van der Sluijs, et al., PMID: 30349098). Evidence supporting this gene-disease relationship includes case-level data and experimental data. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism for disease is haploinsufficiency (Hoyer, et al., PMID: 22405089). The gene-disease association is also supported by animal and cell culture models. Noteworthy, Coffin-Siris syndrome can be caused by variants in additional genes, including ARID1A, SMARCB1, SMARCA4, SMARCE1, ARID2, DPF2, SMARCC2, SOX11, and SOX4 (see OMIM). In summary, ARID1B is definitively associated with autosomal dominant Coffin-Siris syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 12/02/19 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c95022e4-ff23-4000-816d-b5bfcc4a5e0f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2019-12-04T20:07:34.569Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d057c34b-e6e7-400a-b2a6-a55a01ff032c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is also a frameshift variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82f42eaa-4a32-4061-9756-c76ec785dd78","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2445","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":15,"detectionMethod":"Libraries of all coding exons and exon–intron boundaries of the known Coffin-Siris syndrome genes ARID1A (NM_006015.4), ARID1B(NM_020732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_001128849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_003079.4), as well as the candidate genes ARID2 (NM_152641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_001098426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_004301.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4), BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1 (NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_018063.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2 (NM_007373.3) were prepared from 200 ng of genomic DNA from 41 index individuals. The resulting fragment libraries were sequenced from both ends (100 bp paired-end sequencing).","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"prominent interphalangeal joints, prominent distal phalanges","phenotypes":["obo:HP_0011968","obo:HP_0000219","obo:HP_0009835","obo:HP_0000294","obo:HP_0000445","obo:HP_0010185","obo:HP_0008386","obo:HP_0000154","obo:HP_0002209","obo:HP_0005280","obo:HP_0001273","obo:HP_0000508","obo:HP_0000343","obo:HP_0000574","obo:HP_0000365","obo:HP_0001290","obo:HP_0009928","obo:HP_0001007","obo:HP_0000527","obo:HP_0000664","obo:HP_0001249","obo:HP_0000179","obo:HP_0001263","obo:HP_0007392","obo:HP_0000280","obo:HP_0000680","obo:HP_0000158","obo:HP_0000598"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d057c34b-e6e7-400a-b2a6-a55a01ff032c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/a94edd12-2fbf-48e3-a23f-14c5b154b747","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.4532_4533insTGCTGCTGCTCCTACTCGG (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940436"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/46469e62-d5c9-4962-842c-0ecc0b07af3a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a nonsense variant. The variant was also detected in one additional unrelated individual in another publication (PMID: 30349098)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8878a63b-f142-4a22-b044-c5f0d9568365","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2474","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":84,"detectionMethod":"Libraries of all coding exons and exon–intron boundaries of the known Coffin-Siris syndrome genes ARID1A (NM_006015.4), ARID1B(NM_020732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_001128849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_003079.4), as well as the candidate genes ARID2 (NM_152641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_001098426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_004301.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4), BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1 (NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_018063.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2 (NM_007373.3) were prepared from 200 ng of genomic DNA from 41 index individuals. The resulting fragment libraries were sequenced from both ends (100 bp paired-end sequencing).","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"prominent interphalangeal joints, prominent distal phalanges","phenotypes":["obo:HP_0000280","obo:HP_0000527","obo:HP_0045025","obo:HP_0006118","obo:HP_0000708","obo:HP_0001249","obo:HP_0000445","obo:HP_0009928","obo:HP_0000219","obo:HP_0005280","obo:HP_0000664","obo:HP_0000574","obo:HP_0000154","obo:HP_0000598","obo:HP_0001263","obo:HP_0000158","obo:HP_0001290","obo:HP_0000179","obo:HP_0000294"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/46469e62-d5c9-4962-842c-0ecc0b07af3a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/75400e46-e349-4ba1-b880-4095078ef067","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020732.3(ARID1B):c.2692C>T (p.Arg898Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203785"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0a19dfe7-8be3-4f29-a5c6-ab345af1db12_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is also a frameshift variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0f71f20-5188-4b3d-ab17-43d36dc9f3fa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2444","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":36,"detectionMethod":"Libraries of all coding exons and exon–intron boundaries of the known Coffin-Siris syndrome genes ARID1A (NM_006015.4), ARID1B(NM_020732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_001128849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_003079.4), as well as the candidate genes ARID2 (NM_152641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_001098426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_004301.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4), BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1 (NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_018063.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2 (NM_007373.3) were prepared from 200 ng of genomic DNA from 41 index individuals. The resulting fragment libraries were sequenced from both ends (100 bp paired-end sequencing).","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000486","obo:HP_0002209","obo:HP_0005280","obo:HP_0000154","obo:HP_0000463","obo:HP_0000527","obo:HP_0011968","obo:HP_0001249","obo:HP_0001263","obo:HP_0000574","obo:HP_0000639","obo:HP_0001007","obo:HP_0009928","obo:HP_0001273"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0a19dfe7-8be3-4f29-a5c6-ab345af1db12_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/0380a328-81df-48ce-9e75-f02cc6143cf7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.5086_5087delinsG (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940437"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/57a62ef7-4f9a-4715-88ae-ff089785bb8b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is also a frameshift variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70954562-3d75-45f0-baf6-f07af867586b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2437","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":30,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000322","obo:HP_0000527","obo:HP_0001290","obo:HP_0000680","obo:HP_0000598","obo:HP_0009835","obo:HP_0002719","obo:HP_0001249","obo:HP_0000154","obo:HP_0000574","obo:HP_0012471","obo:HP_0000294","obo:HP_0009928","obo:HP_0001007","obo:HP_0011968","obo:HP_0008386","obo:HP_0000280","obo:HP_0001263"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/57a62ef7-4f9a-4715-88ae-ff089785bb8b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d0f2fa3-370e-448e-aa70-658976c98a64","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.1623dup (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940433"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6500e286-1dc8-4a6b-adb7-a93231021347_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is also a frameshift variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10080daa-04a3-47a3-945b-75e340b2b77d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2574","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Libraries of all coding exons and exon–intron boundaries of the known Coffin-Siris syndrome genes ARID1A (NM_006015.4), ARID1B(NM_020732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_001128849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_003079.4), as well as the candidate genes ARID2 (NM_152641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_001098426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_004301.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4), BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1 (NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_018063.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2 (NM_007373.3) were prepared from 200 ng of genomic DNA from 41 index individuals. The resulting fragment libraries were sequenced from both ends (100 bp paired-end sequencing).","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0001007","obo:HP_0000107","obo:HP_0000680","obo:HP_0000508","obo:HP_0001290","obo:HP_0000179","obo:HP_0000574","obo:HP_0007392","obo:HP_0000158","obo:HP_0000280","obo:HP_0001212","obo:HP_0000219","obo:HP_0002750","obo:HP_0009835","obo:HP_0005280","obo:HP_0000445","obo:HP_0000664","obo:HP_0008386","obo:HP_0000154","obo:HP_0001249","obo:HP_0000322","obo:HP_0001263","obo:HP_0011968","obo:HP_0000294","obo:HP_0000527","obo:HP_0010185","obo:HP_0009928"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6500e286-1dc8-4a6b-adb7-a93231021347_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/835de0c1-35c7-45dd-a225-72cb046a7dbc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.1891dup (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940434"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8851c418-3d12-4ccf-9961-5c252e8906de_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is also a frameshift variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e04f3779-9aa2-4afc-bf51-2b6c705a2b9f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2471","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":1,"detectionMethod":"Libraries of all coding exons and exon–intron boundaries of the known Coffin-Siris syndrome genes ARID1A (NM_006015.4), ARID1B(NM_020732.3), SMARCA2 (NM_003070.3), SMARCA4 (NM_001128849.1), SMARCB1 (NM_003073.3), and SMARCE1 (NM_003079.4), as well as the candidate genes ARID2 (NM_152641.2), SMARCC1 (NM_003074.3), SMARCC2 (NM_003075.3), SMARCD1 (NM_003076.4), SMARCD2 (NM_001098426.1), SMARCD3 (NM_003078.3), ACTL6A (NM_004301.3), ACTL6B (NM_016188.4), PBRM1 (NM_018313.4), BRD7 (NM_001173984.2), PRMT5 (NM_006109.3), SMARCA1 (NM_003069.3), SMARCA5 (NM_003601.3), HELLS (NM_018063.3), CBL (NM_005188.3), C7orf11 (NM_138701) and SHOC2 (NM_007373.3) were prepared from 200 ng of genomic DNA from 41 index individuals. The resulting fragment libraries were sequenced from both ends (100 bp paired-end sequencing).","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000154","obo:HP_0000179","obo:HP_0002750","obo:HP_0002209","obo:HP_0001290","obo:HP_0001007","obo:HP_0000598","obo:HP_0002719","obo:HP_0000527","obo:HP_0001263","obo:HP_0000664","obo:HP_0006118","obo:HP_0000445","obo:HP_0000028","obo:HP_0000718","obo:HP_0000158","obo:HP_0011968","obo:HP_0008386","obo:HP_0000574","obo:HP_0000343","obo:HP_0045025","obo:HP_0001249","obo:HP_0000219","obo:HP_0000294","obo:HP_0009928","obo:HP_0000280","obo:HP_0001250","obo:HP_0000486"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8851c418-3d12-4ccf-9961-5c252e8906de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/e21f5939-d84a-401f-bb50-0d17a4c401e4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.2848del (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940435"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b8bef46b-474e-4974-a44a-6b479c16fa1b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a canonical donor splice site variant. Sanger sequencing of the proband's cDNA sample revealed that the variant leads to skipping of exon 19 (131 bp in length), predicted to result in a translational frameshift of 11 amino acids and the formation of a premature termination codon (truncating of 1,633 amino acid NP_065783.3:p.(Thr1633Valfs*11))","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbd98821-89d2-4386-8ac2-db1ea1506b96","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31628733","rdfs:label":"1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000194","obo:HP_0000294","obo:HP_0000280","obo:HP_0002317","obo:HP_0000527","obo:HP_0008386","obo:HP_0000179","obo:HP_0001249","obo:HP_0001659","obo:HP_0001156","obo:HP_0006376","obo:HP_0001290","obo:HP_0002209","obo:HP_0000574","obo:HP_0002719","obo:HP_0001634","obo:HP_0001273","obo:HP_0002307","obo:HP_0000598","obo:HP_0001513","obo:HP_0001382","obo:HP_0011003","obo:HP_0001007","obo:HP_0001763","obo:HP_0001263","obo:HP_0100307","obo:HP_0004209"],"previousTesting":true,"previousTestingDescription":"negative for cytogenetic test","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b8bef46b-474e-4974-a44a-6b479c16fa1b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31628733","allele":{"id":"https://genegraph.clinicalgenome.org/r/b43438ae-015b-4c1d-b58c-f6a52016ed52","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_002956289.1(ARID1B):n.5341+2T>C (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA366244421"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ae34f104-7837-41e4-aa2b-27bd4e5e5f35_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant was also found in one additional unrelated individual in the same publication (PMID: 23906836) and one additional unrelated individual in another publication (PMID: 30349098)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d49ba87-7beb-4450-afd1-3b3ca03a1ef7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","rdfs:label":"K2434","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"prominent interphalangeal joints, prominent distal phalanges","phenotypes":["obo:HP_0011968","obo:HP_0000445","obo:HP_0001250","obo:HP_0000527","obo:HP_0002719","obo:HP_0005280","obo:HP_0009835","obo:HP_0000508","obo:HP_0000280","obo:HP_0000154","obo:HP_0001290","obo:HP_0000574","obo:HP_0002209","obo:HP_0001249","obo:HP_0000219","obo:HP_0000322","obo:HP_0001263","obo:HP_0000294","obo:HP_0010185"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae34f104-7837-41e4-aa2b-27bd4e5e5f35_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/51005d95-b5db-4884-b874-2a6558af9e78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020732.3(ARID1B):c.2248C>T (p.Arg750Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA207644"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d487e6c4-9727-4315-90a2-11338128a8e5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84613240-8972-4b97-a888-e817a1e0109b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9b8729b-c710-406e-826b-9fc05a61f46f","type":"Finding","dc:description":"GABAergic interneurons play an important role in neural circuitry and in emotional and cognitive behaviors. The balance of excitatory and inhibitory neurotransmission is essential for controlling memory and emotional behaviors and is disrupted in ASD and intellectual disability. Reduction of inhibitory signaling is particularly involved in ASD-like behaviors in humans and in mouse models of ASD. Proper positioning and differentiation of interneurons during brain development are important for establishing anatomical and functional circuitry necessary for normal cognition.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29184203","rdfs:label":"heterozygous knockout of Arid1b in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4c0d7738-7478-4c1e-8bc8-27b3e80c16c0","type":"EvidenceLine","dc:description":"Downgrade the score due to 1) knockdown the gene of interest in non-human cell line and 2) simply detecting morphological changes in neurite outgrowth without further electrophysiological characterization","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43cdaa05-37b3-47ca-b35e-388bda330c58","type":"Finding","dc:description":"loss of ARID1B modulates neurite behavior in a beta-catenin-dependent fashion and is supportive of an ARID1B function in brain and neuronal physiology","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26340334","rdfs:label":"Knockdown of ARID1B in mouse neuroblastoma cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":105,"specifiedBy":"GeneValidityCriteria6","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/lfq4n2jqpi0","type":"GeneValidityProposition","disease":"obo:MONDO_0015452","gene":"hgnc:18040","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d487e6c4-9727-4315-90a2-11338128a8e5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}